|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn950518647 |
003 |
OCoLC |
005 |
20231120112110.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
160525t20162016ne a ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d YDXCP
|d UIU
|d OPELS
|d EBLCP
|d N$T
|d OCLCF
|d TEFOD
|d MQM
|d GGVRL
|d YDX
|d OCLCO
|d OCLCQ
|d TMC
|d MMU
|d OCLCO
|d USU
|d UIU
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d MERUC
|d LEATE
|d U3W
|d D6H
|d NLE
|d OCLCQ
|d WYU
|d LQU
|d OCLCQ
|d OCLCO
|d OCLCA
|d S2H
|d OCLCO
|d LVT
|d OCLCO
|d OPELS
|d OCLCO
|d OCLCQ
|d CASUM
|d OCLCO
|
019 |
|
|
|a 956735866
|a 1058588992
|a 1097086385
|a 1105188793
|a 1105560975
|a 1141443896
|a 1151762519
|a 1162475615
|a 1229876739
|a 1259586940
|a 1300472123
|
020 |
|
|
|a 9780128020524
|q (electronic bk.)
|
020 |
|
|
|a 0128020520
|q (electronic bk.)
|
020 |
|
|
|z 9780128020258
|q (paperback)
|
020 |
|
|
|z 0128020253
|q (paperback)
|
035 |
|
|
|a (OCoLC)950518647
|z (OCoLC)956735866
|z (OCoLC)1058588992
|z (OCoLC)1097086385
|z (OCoLC)1105188793
|z (OCoLC)1105560975
|z (OCoLC)1141443896
|z (OCoLC)1151762519
|z (OCoLC)1162475615
|z (OCoLC)1229876739
|z (OCoLC)1259586940
|z (OCoLC)1300472123
|
050 |
|
4 |
|a RM301.9
|
060 |
|
4 |
|a WB 330
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.7/04
|2 23
|
245 |
0 |
0 |
|a Clinical challenges in therapeutic drug monitoring :
|b special populations, physiological conditions and pharmacogenomics /
|c edited by William Clarke, Amitava Dasgupta.
|
246 |
3 |
|
|a Therapeutic drug monitoring
|
264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c [2016]
|
264 |
|
4 |
|c �2016
|
300 |
|
|
|a 1 online resource (xvi, 350 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
336 |
|
|
|a still image
|b sti
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Overview of therapeutic drug monitoring -- Immunoassays and issues with interference in therapeutic drug monitoring -- Application of chromatography combined with mass spectrometry in therapeutic drug monitoring -- Monitoring free drug concentration : clinical usefulness and analytical challenges -- Therapeutic drug monitoring of newer antiepileptic drugs -- Therapeutic drug monitoring of antiretrovirals -- Therapeutic drug monitoring in infants and children -- Therapeutic drug monitoring in pregnancy -- Therapeutic drug monitoring in older people -- Therapeutic drug monitoring in obese patients -- Special issues in therapeutic drug monitoring in patients with uremia, liver disease, and in critically ill patients -- Issues of pharmacogenomics in monitoring warfarin therapy -- Alternative sampling strategies for therapeutic drug monitoring -- Integrating therapeutic drug monitoring in the health care environment : therapeutic drug monitoring and pharmacists.
|
520 |
|
|
|a This guide surveys critical issues in therapeutic drug monitoring for non-toxicologists who want to gain greater insight into the unique requirements of special populations and learn how to avoid drug toxicity within a narrow therapeutic window.
|
588 |
0 |
|
|a Online resource; title from resource home page (ClinicalKey, viewed May 9, 2017).
|
650 |
|
0 |
|a Drug monitoring.
|
650 |
1 |
2 |
|a Drug Monitoring
|0 (DNLM)D016903
|
650 |
|
6 |
|a Pharmacovigilance.
|0 (CaQQLa)201-0217159
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug monitoring
|2 fast
|0 (OCoLC)fst00898688
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Clarke, William,
|d 1970-
|e editor.
|
700 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Clinical challenges in therapeutic drug monitoring.
|d Amsterdam : Elsevier, [2016]
|z 0128020253
|w (OCoLC)938383072
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128020258
|z Texto completo
|